Two different initial treatment regimens of ranibizumab in myopic choroidal neovascularization: 12‐Month results from a randomized controlled study—Comment

Ophthalmology Letterbox

“…Correspondence between Cao et al 3 and Li et al 4 centred around the latter group's 2019 paper that reported a randomised controlled trial comparing effectiveness of different ranibizumab treatment protocols for myopic choroidal neovascularisation. In this study, a shorter induction achieved similar outcomes to conventional induction.…”

“…In this study, a shorter induction achieved similar outcomes to conventional induction. Cao et al 3 raised questions about the statistical methodology used in the study, and Li et al 4 had the opportunity to provide additional calculations.…”